search
Back to results

Dealing With Anxiety: A Cognitive Behavioural Program for Diabetes

Primary Purpose

Diabetes Mellitus Type 2

Status
Completed
Phase
Not Applicable
Locations
Australia
Study Type
Interventional
Intervention
Immediate Cognitive behavioural therapy (CBT)
Delayed CBT
Sponsored by
Hunter and New England Health
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Diabetes Mellitus Type 2 focused on measuring diabetes, cognitive behavioural therapy

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Consenting attendees of the Hunter Area Diabetes Services RNH Diabetes Outpatient Clinic

Exclusion Criteria:

  • Accessibility problems including:

    • limited English
    • developmental disability
    • physical immobility
    • geographical distance
    • extreme age/frailty

Sites / Locations

  • Royal Newcastle Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

1

2

Arm Description

Outcomes

Primary Outcome Measures

Hemoglobin A1C (HbA1C)

Secondary Outcome Measures

Depression Anxiety Stress Scale (DASS)
Diabetes Quality of Life (ADDQoL)

Full Information

First Posted
April 14, 2008
Last Updated
April 14, 2008
Sponsor
Hunter and New England Health
search

1. Study Identification

Unique Protocol Identification Number
NCT00659932
Brief Title
Dealing With Anxiety: A Cognitive Behavioural Program for Diabetes
Official Title
Dealing With Anxiety: A Pilot Cognitive Behavioural Program for Diabetic Clinic Outpatient Attendees
Study Type
Interventional

2. Study Status

Record Verification Date
December 2007
Overall Recruitment Status
Completed
Study Start Date
May 2002 (undefined)
Primary Completion Date
March 2005 (Actual)
Study Completion Date
March 2005 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
Hunter and New England Health

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
This study was designed to assess whether a cognitive behavior therapy (CBT) program for diabetes clinic patients was acceptable, improved quality of life and produced measurable change in levels of depression, anxiety and stress.
Detailed Description
Having co-morbid anxiety or depression makes it difficult to carry out the activities for diabetes selfcare. Psychological interventions have been shown to result in improvements in HbA1C and depression. Reports on psychosocial outcomes are conflicting and there are no studies of quality of life. Our diabetes outpatient population has a higher prevalence of anxiety and depression compared to the general public and this led to the development of a group CBT intervention designed to reduce anxiety as a co-morbidity of diabetes.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diabetes Mellitus Type 2
Keywords
diabetes, cognitive behavioural therapy

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Allocation
Randomized
Enrollment
64 (Actual)

8. Arms, Groups, and Interventions

Arm Title
1
Arm Type
Experimental
Arm Title
2
Arm Type
Active Comparator
Intervention Type
Behavioral
Intervention Name(s)
Immediate Cognitive behavioural therapy (CBT)
Intervention Description
The Dealing with Anxiety CBT Group Program comprises 7 group sessions: an initial five hour session followed by 6 three hour sessions over a three month period
Intervention Type
Behavioral
Intervention Name(s)
Delayed CBT
Intervention Description
Commencement of the CBT Group Program is delayed 3 months
Primary Outcome Measure Information:
Title
Hemoglobin A1C (HbA1C)
Time Frame
6 months
Secondary Outcome Measure Information:
Title
Depression Anxiety Stress Scale (DASS)
Time Frame
6 months
Title
Diabetes Quality of Life (ADDQoL)
Time Frame
6 months

10. Eligibility

Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Consenting attendees of the Hunter Area Diabetes Services RNH Diabetes Outpatient Clinic Exclusion Criteria: Accessibility problems including: limited English developmental disability physical immobility geographical distance extreme age/frailty
Facility Information:
Facility Name
Royal Newcastle Hospital
City
Newcastle
State/Province
New South Wales
ZIP/Postal Code
2300
Country
Australia

12. IPD Sharing Statement

Learn more about this trial

Dealing With Anxiety: A Cognitive Behavioural Program for Diabetes

We'll reach out to this number within 24 hrs